Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition-Reference-Cited by-同舟云学术

Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition

Published:2016-04-20 Issue:21 Volume:7 Page:31053-31066
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chen Xue-ying¹,Lv Rui-juan²,Zhang Wei¹,Yan Yu-gang³,Li Peng⁴,Dong Wen-qian¹,Liu Xue¹,Liang Er-shun¹,Tian Hong-liang¹,Lu Qing-hua⁵,Zhang Ming-xiang¹

Affiliation:

1. The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Qilu Hospital of Shandong University, Jinan, Shandong, China

2. Department of Emergency, Qilu Hospital of Shandong University, Jinan, Shandong, China

3. Department of Medicinal Chemistry, School of Pharmacy, Shandong University, Jinan, Shandong, China

4. College of Pharmacy, Xinxiang Medical University, Xinxiang, China

5. Department of Cardiology, The Second Hospital of Shandong University, Jinan, Shandong, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunometabolic Approaches Mitigating Foreign Body Response and Transcriptome Characterization of the Foreign Body Capsule;Advanced Healthcare Materials;2024-08-15

2. Experimental Models to Study Endothelial to Mesenchymal Transition in Myocardial Fibrosis and Cardiovascular Diseases;International Journal of Molecular Sciences;2023-12-27

3. Endothelial-to-Mesenchymal Transition: Potential Target of Doxorubicin-Induced Cardiotoxicity;American Journal of Cardiovascular Drugs;2023-02-26

4. Potential roles of endothelial cells-related non-coding RNAs in cardiovascular diseases;Pathology - Research and Practice;2023-02

5. miR-132-3p and KLF7 as novel regulators of aortic stiffening-associated EndMT in type 2 diabetes mellitus;Diabetology & Metabolic Syndrome;2023-01-25